MCL1 and plasma cell myeloma: For example, MCL-1 inhibition led to significant induction of apoptosis in primary human multiple myeloma samples and amplification of 1q21 (containing MCL-1), which occurs in around 40% of newly diagnosed disease, correlated with sensitivity [167].